3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
3
NIH
1
NETWORK
1
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Sleep Wake Disorders
1
Fatigue
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Anxiety Disorders
1
Interventions
Radiotherapy
87
Cyclophosphamide
84
Cisplatin
79
Doxorubicin
66
Vincristine
62
Paclitaxel
55
Etoposide
50
Carboplatin
49
Filgrastim
48
Methotrexate
41
Prednisone
40
Cytarabine
37
Granulocyte Colony-Stimulating Factor
35
Radiotherapy, Intensity-Modulated
31
Platinum
31
Docetaxel
31
Gemcitabine
30
Leucovorin
28
Dexamethasone
28
Radiotherapy, Conformal
27
Fluorouracil
27
Cetuximab
26
Taxes
24
Rituximab
23
Irinotecan
23
1,2-diaminocyclohexaneplatinum II citrate
23
Radiation
21
merphos
20
Bevacizumab
19
Temozolomide
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Has results
×
Exercise Test
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts